Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: A meta-analysis of 14 cohort studies

Diabetes Care

Volumn 33, Issue 12, 2010, Pages 2684-2691

  Nettleton, Jennifer A ^a   McKeown, Nicola M ^b   Kanoni, Stavroula ^c   Lemaitre, Rozenn N ^d   Hivert, Marie France ^e   Ngwa, Julius ^f   Van Rooij, Frank J A ^g,h   Sonestedt, Emily ⁱ   Wojczynski, Mary K ^j   Ye, Zheng ^k   Tanaka, Tosh ^l   Garcia, Melissa ^l   Anderson, Jennifer S ^m   Follis, Jack L ^a   Djousse, Luc ^n,o   Mukamal, Kenneth ^p   Papoutsakis, Constantina ^c   Mozaffarian, Dariush ^q   Zillikens, M Carola ^g,h   Bandinelli, Stefania ^r   Bennett, Amanda J ^s   Borecki, Ingrid B ^j   Feitosa, Mary F ^j   Ferrucci, Luigi ^l   Forouhi, Nita G ^k   Groves, Christopher J ^t,u   Hallmans, Goran ^v   Harris, Tamara ^l   Hofman, Albert ^g,h   Houston, Denise K ^m   Hu, Frank B ⁿ   Johansson, Ingegerd ^v   Kritchevsky, Stephen B ^m   Langenberg, Claudia ^k   Launer, Lenore ^l   Liu, Yongmei ^m   Loos, Ruth J ^k   Nalls, Michael ^l   Orho Melander, Marju ⁱ   Renstrom, Frida ^w   Rice, Kenneth ^d   Riserus, Ulf ^x   Rolandsson, Olov ^v   Rotter, Jerome I ^y   Saylor, Georgia ^m   Sijbrands, Eric J G ^g,h   Sjogren, Per ^w   Smith, Albert ^z   Steingrímsdóttir, Laufey ^z,aa   Uitterlinden, André G ^g,h   Wareham, Nicholas J ^k   Prokopenko, Inga ^s   Pankow, James S ^ab   Van Duijn, Cornelia M ^g,h   Florez, Jose C ^q,ac,ad   Witteman, Jacqueline C M ^g,h   Dupuis, Josée ^f,ae   Dedoussis, George V ^c   Ordovas, Jose M ^b   Ingelsson, Erik ^af   Cupples, L Adrienne ^f   Siscovick, David S ^d   Franks, Paul W ^i,w   Meigs, James B ^ac   more..

^a UNIVERSITY OF TEXAS   (United States)

^b TUFTS UNIVERSITY   (United States)

^c HAROKOPIO UNIVERSITY   (Greece)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h Netherlands Genomics Initiative   (Netherlands)

ⁱ LUND UNIVERSITY   (Sweden)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k ADDENBROOKE S HOSPITAL   (United Kingdom)

^l NATIONAL INSTITUTE ON AGING   (United States)

^m WAKE FOREST UNIVERSITY   (United States)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o VETERANS AFFAIRS MEDICAL CENTER   (United States)

^p BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^q HARVARD MEDICAL SCHOOL   (United States)

^r Azienda Sanitaria di Firenze   (Italy)

^s CHURCHILL HOSPITAL   (United Kingdom)

^t UNIVERSITY OF OXFORD   (United Kingdom)

^u UNIVERSITY OF OXFORD   (United Kingdom)

^v UMEÅ UNIVERSITY   (Sweden)

^w UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^x UPPSALA UNIVERSITY   (Sweden)

^y CEDARS SINAI MEDICAL CENTER   (United States)

^z ICELANDIC HEART ASSOCIATION   (Iceland)

^aa UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^ab UNIVERSITY OF MINNESOTA   (United States)

^ac MASSACHUSETTS GENERAL HOSPITAL   (United States)

^ad BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^ae FRAMINGHAM HEART STUDY   (United States)

^af KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ALLELE; BODY MASS; COHORT ANALYSIS; DEMOGRAPHY; DIETARY INTAKE; EUROPE; FEMALE; FOOD INTAKE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GRAIN; HUMAN; INSULIN BLOOD LEVEL; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BLOOD GLUCOSE; CEREALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INSULIN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77958562031     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1150     Document Type: Review

References (32)

1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403 (Pubitemid 34437694)
2. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355:241-250 (Pubitemid 44079339)
3. Corella D, Peloso G, Arnett DK, Demissie S, Cupples LA, Tucker K, Lai CQ, Parnell LD, Coltell O, Lee YC, Ordovas JM. APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch Intern Med 2009;169:1897-1906
4. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31(Suppl.)2008;1:S61-S78
5. Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr 2009;89:1256-1262
6. Fisher E, Boeing H, Fritsche A, Doering F, Joost HG, Schulze MB. Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr 2009;101:478-481
7. Qi L, Cornelis MC, Zhang C, van Dam RM, Hu FB. Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. Am J Clin Nutr 2009;89:1453-1458
8. Qi L, Liang J. Interactions between genetic factors that predict diabetes and dietary factors that ultimately impact on risk of diabetes. Curr Opin Lipidol 2009;21: 31-37
9. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet 2006;7:812-820 (Pubitemid 44413225)
10. Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 2007;8: 657-662 (Pubitemid 47281993)
11. Grant RW, Moore AF, Florez JC. Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care 2009;32:1107-1114
12. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL, Lindgren CM, Magi R, Morris AP, Randall J, Johnson T, Elliott P, Rybin D, Thorleifsson G, Steinthorsdottir V, Henneman P, Grallert H, Dehghan A, Hottenga JJ, Franklin CS, Navarro P, Song K, Goel A, Perry JR, Egan JM, Lajunen T, Grarup N, Sparso T, Doney A, Voight BF, Stringham HM, Li M, Kanoni S, Shrader P, Cavalcanti-Proenca C, Kumari M, Qi L, Timpson NJ, Gieger C, Zabena C, Rocheleau G, Ingelsson E, An P, O'Connell J, Luan J, Elliott A, McCarroll SA, Payne F, Roccasecca RM, Pattou F, Sethupathy P, Ardlie K, Ariyurek Y, Balkau B, Barter P, Beilby JP, Ben-Shlomo Y, Benediktsson R, Bennett AJ, Bergmann S, Bochud M, Boerwinkle E, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Bottcher Y, Brunner E, Bumpstead SJ, Charpentier G, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Cornelis M, Crawford G, Crisponi L, Day IN, de Geus EJ, Delplanque J, Dina C, Erdos MR, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Fox CS, Frants R, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Groves CJ, Grundy S, Gwilliam R, Gyllensten U, Hadjadj S, Hallmans G, Hammond N, Han X, Hartikainen AL, Hassanali N, Hayward C, Heath SC, Hercberg S, Herder C, Hicks AA, Hillman DR, Hingorani AD, Hofman A, Hui J, Hung J, Isomaa B, Johnson PR, Jorgensen T, Jula A, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Lyssenko V, Mahley R, Mangino M, Manning AK, Martinez-Larrad MT, McAteer JB, McCulloch LJ, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Morken MA, Mukherjee S, Naitza S, Narisu N, Neville MJ, Oostra BA, Orru M, Pakyz R, Palmer CN, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Perola M, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Psaty BM, Rathmann W, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Roden M, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Scott LJ, Seedorf U, Sharp SJ, Shields B, Sigurethsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvanen AC, Tanaka T, Thorand B, Tichet J, Tonjes A, Tuomi T, Uitterlinden AG, van Dijk KW, van Hoek M, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Walters GB, Ward KL, Watkins H, Weedon MN, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zeggini E, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC, Borecki IB, Loos RJ, Meneton P, Magnusson PK, Nathan DM, Williams GH, Hattersley AT, Silander K, Salomaa V, Smith GD, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Dedoussis GV, Serrano- Rios M, Morris AD, Lind L, Palmer LJ, Hu FB, Franks PW, Ebrahim S, Marmot M, Kao WH, Pankow JS, Sampson MJ, Kuusisto J, Laakso M, Hansen T, Pedersen O, Pramstaller PP, Wichmann HE, Illig T, Rudan I, Wright AF, Stumvoll M, Campbell H, Wilson JF, Bergman RN, Buchanan TA, Collins FS, Mohlke KL, Tuomilehto J, Valle TT, Altshuler D, Rotter JI, Siscovick DS, Penninx BW, Boomsma DI, Deloukas P, Spector TD, Frayling TM, Ferrucci L, Kong A, Thorsteinsdottir U, Stefansson K, van Duijn CM, Aulchenko YS, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Waterworth DM, Vollenweider P, Peltonen L, Mooser V, Abecasis GR, Wareham NJ, Sladek R, Froguel P, Watanabe RM, Meigs JB, Groop L, Boehnke M, Mc- Carthy MI, Florez JC, Barroso I. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-116
13. Pearson H. Genetic testing for everyone. Nature 2008;453:570-571
14. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle-will we get our wish? N Engl J Med 2008;358: 105-107
15. Positively disruptive. Nat Genet 2008;40: 119
16. Burke W, Psaty BM. Personalized medicine in the era of genomics. JAMA 2007; 298:1682-1684 (Pubitemid 47606657)
17. Gulcher J, Stefansson K. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2009; 360:1360; author reply 360:1361
18. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ, Dehghan A, Deloukas P, Doney AS, Elliott P, Freimer N, Gateva V, Herder C, Hofman A, Hughes TE, Hunt S, Illig T, Inouye M, Isomaa B, Johnson T, Kong A, Krestyaninova M, Kuusisto J, Laakso M, Lim N, Lindblad U, Lindgren CM, McCann OT, Mohlke KL, Morris AD, Naitza S, Orru M, Palmer CN, Pouta A, Randall J, Rathmann W, Saramies J, Scheet P, Scott LJ, Scuteri A, Sharp S, Sijbrands E, Smit JH, Song K, Steinthorsdottir V, Stringham HM, Tuomi T, Tuomilehto J, Uitterlinden AG, Voight BF, Waterworth D, Wichmann HE, Willemsen G, Witteman JC, Yuan X, Zhao JH, Zeggini E, Schlessinger D, Sandhu M, Boomsma DI, Uda M, Spector TD, Penninx BW, Altshuler D, Vollenweider P, Jarvelin MR, Lakatta E, Waeber G, Fox CS, Peltonen L, Groop LC, Mooser V, Cupples LA, Thorsteinsdottir U, Boehnke M, Barroso I, Van Duijn C, Dupuis J, Watanabe RM, Stefansson K, McCarthy MI, Wareham NJ, Meigs JB, Abecasis GR. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009;41: 77-81
19. Psaty BM, O'Donnel CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JL, Uitterlinden AG, Harris TB, Witteman JCM, Boerwinkle E. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from five cohorts. Circ Cardiovasc Genet 2009;2:73-80
20. Jacobs DR, Jr, Meyer KA, Kushi LH, Folsom AR. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr 1998; 68:248-257 (Pubitemid 28355640)
21. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM, Williams R. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996;143:1219-1228 (Pubitemid 26178734)
22. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 2002;76: 390-398 (Pubitemid 34804062)
23. Pereira MA, Jacobs DR Jr, Pins JJ, Raatz SK, Gross MD, Slavin JL, Seaquist ER. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 2002;75:848-855 (Pubitemid 34441253)
24. Murtaugh MA, Jacobs DR Jr, Jacob B, Steffen LM, Marquart L. Epidemiological support for the protection of whole grains against diabetes. Proc Nutr Soc 2003;62: 143-149 (Pubitemid 36569821)
25. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 2007; 4:e261
26. Shiota M, Postic C, Fujimoto Y, Jetton TL, Dixon K, Pan D, Grimsby J, Grippo JF, Magnuson MA, Cherrington AD. Glucokinase gene locus transgenic mice are resistant to the development of obesityinduced type 2 diabetes. Diabetes 2001; 50:622-629 (Pubitemid 32195228)
27. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Bostrom K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton- Cheh C, Nilsson P, Orho-Melander M, Rastam L, Speliotes EK, Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjogren M, Sterner M, Surti A, Svensson M, Svensson M, Tewhey R, Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336
28. Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, Tewhey R, Rieder MJ, Hall J, Abecasis G, Tai ES, Welch C, Arnett DK, Lyssenko V, Lindholm E, Saxena R, de Bakker PI, Burtt N, Voight BF, Hirschhorn JN, Tucker KL, Hedner T, Tuomi T, Isomaa B, Eriksson KF, Taskinen MR, Wahlstrand B, Hughes TE, Parnell LD, Lai CQ, Berglund G, Peltonen L, Vartiainen E, Jousilahti P, Havulinna AS, Salomaa V, Nilsson P, Groop L, Altshuler D, Ordovas JM, Kathiresan S. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and Creactive protein but lower fasting glucose concentrations. Diabetes 2008;57:3112-3121
29. Beer NL, Tribble ND, McCulloch LJ, Roos C, Johnson PR, Orho-Melander M, Gloyn AL. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 2009;18:4081-4088
30. Wong MY, Day NE, Luan JA, Wareham NJ. Estimation of magnitude in gene-environment interactions in the presence of measurement error. Stat Med 2004;23: 987-998 (Pubitemid 38344234)
31. Kristal AR, Peters U, Potter JD. Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 2005;14:2826-2828
32. Murcray CE, Lewinger JP, Gauderman WJ. Gene-environment interaction in genome-wide association studies. Am J Epidemiol 2009;169:219-226